Epigenomics has named the first members for its new colorectal cancer medical advisory board. Appointees include Douglas Rex, professor of medicine at Indiana University’s School of Medicine; Philip Schoenfeld, associate professor in the department of internal medicine at the University of Michigan’s School of Medicine; Deborah Fisher, assistant professor of medicine at Duke University; and Scott Ramsey, associate professor of medicine and health services at the Fred Hutchinson Cancer Research Center.
Â
Â
Fran Tuttle has been appointed to join Xceed Molecular’s board of trustees. Tuttle is president and CEO of HX Diagnostics, and formerly was CEO of Protedyne and senior VP of near patient testing at Bayer Diagnostics. Before that she worked at Chiron Diagnostics.